Literature DB >> 1696930

Anti-idiotypic antibodies counteract the invasion inhibition capacity of antibodies to major epitopes of the Plasmodium falciparum antigen Pf155/RESA.

B Wåhlin1, K Berzins, H Perlmann, R F Anders, P Perlmann.   

Abstract

Rabbits were immunized with the synthetic peptide EENVEHDA or (EENV)2, corresponding to a tandemly repeated sequence in the C-terminal part of the Plasmodium falciparum antigen Pf155/RESA, or with Escherichia coli-derived fusion proteins containing the corresponding repeats. For all sera, the capacity of the total immunoglobulin G fractions to inhibit P. falciparum merozoite invasion in vitro was similar and relatively low. Affinity purification of Pf155/RESA-specific antibodies on parasite-infected erythrocyte monolayers or on peptide columns increased the inhibitory capacity 50 to 5,000 times, whereas the immunofluorescence titers were increased only 10 times. The addition of small amounts of total immunoglobulin G to the affinity-purified antibodies gave a marked and dose-dependent reduction of the inhibitory capacity of the purified antibodies. However, this reduction was only seen in combinations where the immunoglobulin G fraction was from the same serum as the affinity-purified antibodies, suggesting that it was mediated by anti-idiotypic antibodies reacting with non-cross-reacting idiotopes of the invasion-inhibiting antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696930      PMCID: PMC313572          DOI: 10.1128/iai.58.9.2815-2820.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Gamma-globulin and acquired immunity to human malaria.

Authors:  S COHEN; I A McGREGOR; S CARRINGTON
Journal:  Nature       Date:  1961-11-25       Impact factor: 49.962

2.  Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum.

Authors:  W E Collins; R F Anders; M Pappaioanou; G H Campbell; G V Brown; D J Kemp; R L Coppel; J C Skinner; P M Andrysiak; J M Favaloro
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

3.  Absence of antigenic diversity in Pf155, a major parasite antigen in membranes of erythrocytes infected with Plasmodium falciparum.

Authors:  H K Perlmann; K Berzins; B Wåhlin; R Udomsangpetch; W Ruangjirachuporn; M Wahlgren; P H Perlmann
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

4.  Enhancement or inhibition of Plasmodium falciparum erythrocyte reinvasion in vitro by antibodies to an asparagine rich protein.

Authors:  L Franzén; B Wåhlin; M Wahlgren; L Aslund; P Perlmann; H Wigzell; U Pettersson
Journal:  Mol Biochem Parasitol       Date:  1989-01-15       Impact factor: 1.759

Review 5.  Criteria to define anti-idiotypic antibodies carrying the internal image of an antigen.

Authors:  H C Ertl; C A Bona
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641

6.  Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria.

Authors:  J S Peiris; S Premawansa; M B Ranawaka; P V Udagama; Y D Munasinghe; M V Nanayakkara; C P Gamage; R Carter; P H David; K N Mendis
Journal:  Am J Trop Med Hyg       Date:  1988-07       Impact factor: 2.345

7.  Monoclonal antibodies to a synthetic peptide corresponding to a repeated sequence in the Plasmodium falciparum antigen Pf155.

Authors:  W Ruangjirachuporn; B Wåhlin; H Perlmann; J Carlsson; K Berzins; M Wahlgren; R Udomsangpetch; H Wigzell; P Perlmann
Journal:  Mol Biochem Parasitol       Date:  1988-05       Impact factor: 1.759

Review 8.  Malaria vaccines: immunogen selection and epitope mapping.

Authors:  P Perlmann; K Berzins; H Perlmann; M Troye-Blomberg; M Wahlgren; B Wåhlin
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641

9.  Research toward malaria vaccines.

Authors:  L H Miller; R J Howard; R Carter; M F Good; V Nussenzweig; R S Nussenzweig
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

Review 10.  Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components.

Authors:  H Perlmann; P Perlmann; K Berzins; B Wåhlin; M Troye-Blomberg; M Hagstedt; I Andersson; B Högh; E Petersen; A Björkman
Journal:  Immunol Rev       Date:  1989-12       Impact factor: 12.988

View more
  1 in total

1.  Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA.

Authors:  K Berzins; H Perlmann; B Wåhlin; H P Ekre; B Högh; E Petersen; B Wellde; M Schoenbechler; J Williams; J Chulay
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.